microscopic evidence of pseudohyphae and/or budding yeast
1 drugsPredictive biomarker for patient selection in 2 indications
1
Approved Drugs
2
Indications
1
Companies
microscopic evidence of pseudohyphae and/or budding yeast is a precision-medicine biomarker linked to 1 FDA-approved targeted drug from 1 company, spanning 2 indications including Diaper Dermatitis, Candidiasis. Explore the targeted therapies, indications, testing methods, and companies developing microscopic evidence of pseudohyphae and/or budding yeast drugs below.
Search microscopic evidence of pseudohyphae and/or budding yeast Clinical Trials
Search recruiting trials on ClinicalTrials.gov
Drugs Targeting microscopic evidence of pseudohyphae and/or budding yeast
| Drug | Company | Therapeutic Area |
|---|---|---|
| VUSION | Viatris | Infectious Disease |
microscopic evidence of pseudohyphae and/or budding yeast Indications
Diaper Dermatitis Candidiasis